Pfizer ends research for Alzheimer's, Parkinson's drugs | News | Al Jazeera

Pfizer ends research for Alzheimer's, Parkinson's drugs

The drug company - which makes the lucrative drug, Viagra - said it was ending its neuroscience research to focus on areas where it was strongest.

by

    Alzheimer's and Parkinson's sufferers have been dealt a blow, with drug maker Pfizer deciding to end its research into the debilitating diseases.

    Many sufferers and their families had felt new hope when the pharmaceutical giant began early-stage research, but the company has now decided to invest elsewhere.

    Al Jazeera's John Hendren reports.


    YOU MIGHT ALSO LIKE

    Interactive: Coding like a girl

    Interactive: Coding like a girl

    What obstacles do young women in technology have to overcome to achieve their dreams? Play this retro game to find out.

    The State of Lebanon

    The State of Lebanon

    Amid deepening regional rivalries what does the future hold for Lebanon's long established political dynasties?

    Exploited, hated, killed: The lives of African fruit pickers

    Exploited, hated, killed: Italy's African fruit pickers

    Thousands of Africans pick fruit and vegetables for a pittance as supermarkets profit, and face violent abuse.